contentsubscribe

All issues online, mobile friendly. Works on mobile, tablets & desktop.

NLS

June 24, 2017

Published: June 24, 2017

South Korea to grant precision medicine patent to Diamyd Medical

The South Korean Patent Office will grant a patent protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients with the HLA DR4-DQ8 genetic marker.

Global report – January 21, 2025

Trump announces US withdrawal from WHO

President Donald Trump announced on Monday January 20 that the United States will leave the World Health Organization (WHO).

Biotech article – January 21, 2025

First Danish patients treated with gene therapy for haemophilia B

CSL Behring Denmark has announced that the first Danish patients with haemophilia B were treated with the gene therapy HEMGENIX (etranacogene dezaparvovec).

New Market – January 20, 2025

AstraZeneca’s Datroway approved in the US

First approval in the US for AstraZeneca and Daiichi Sankyo’s Datroway based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or death vs. chemotherapy.